疾病严重程度和左心室心力衰竭结果的性别特异性差异:全国范围的队列研究
Anastasia Janina Hobbach1, Jannik Feld2, Jeanette Köppe2
1Department of Cardiology I, Peripheral Vascular Disease and Heart Failure University Hospital, Albert-Schweizer Campus 1, 48149, Münster, Germany. Anastasia.Hobbach@ukmuenster.de.
概括
性别和心力衰竭阶段显著影响左心室心力衰竭 (LVHF) 的结果和成本. 虽然女性的整体死亡率较高,但男性在大多数子组的结果较差,需要量身定制的管理策略.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
背景情况:
- 左心室心力衰竭 (LVHF) 是致病率和死亡率的主要原因.
- 现有的研究表明,在LVHF呈现和结果中,性别特异性差异很大.
- 根据纽约心脏协会 (NYHA) 分类的疾病严重程度对这些性别差异的影响尚未完全理解.
研究的目的:
- 调查性别和NYHA分类对LVHF患者临床结果的影响.
- 分析性别和NYHA分类对与LVHF住院治疗相关的医疗保健成本的影响.
- 确定 LVHF 患者住院死亡率的性别和阶段特定预测因素.
主要方法:
- 分析了2014-2022年德国LVHF住院病例的大数据集 (2.616.462例) 的分析.
- 根据性别和NYHA阶段的病例分层 (I-IV).
- 使用多变量后勤回归评估基线特征,并发病,住院结果 (包括死亡率) 和医疗保健成本.
主要成果:
- 女性在较早的NYHA阶段更常被诊断出患病,而男性在较晚的阶段占主导地位.
- 总体而言,女性 (8.34%) 的住院死亡率高于男性 (7.90%),但在大多数年龄和NYHA子组中,男性的死亡率更高.
- 尽管住院时间较短,但在NYHA III和IV阶段,男性的医疗费用较高. NYHA阶段是最强的死亡率预测因素,而女性性别和肥胖与较低的死亡率有关.
结论:
- 在LVHF中,临床结果和医疗费用受到性别和NYHA阶段的重大影响.
- 虽然女性的整体死亡率较高,但男性在特定子组的结果较差,突出了复杂的基于性别的模式.
- 调查结果强调,发展和实施特定于性别和阶段的LVHF管理策略至关重要.
相关概念视频
Heart Failure III: Clinical Manifestations
692
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
692
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Pathophysiology of Heart Failure
4.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
Heart Failure IV: Classification and Diagnostic Evaluation
466
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
466
Cardiomyopathy III: Hypertrophic Cardiomyopathy
553
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
553
Mitral Stenosis I: Introduction
888
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
888


